Atlas Trials

Study to Evaluate the Effect of Bimosiamose on Ozone Induced Sputum Neutrophilia

Clinical trial NCT00962481 · COMPLETED

Trial details

NCT number
NCT00962481
Sponsor
Revotar Biopharmaceuticals AG
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.